MiR-484 showed a transcriptional downregulation in a large cohort of CLL patients, mediated via a downregulation of the TF MDS1 and EVI1 complex locus (MECOM, also called EVI1). This evidence concerns the gene MECOM and B-cell chronic lymphocytic leukemia.